Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives)
Study Details
Study Description
Brief Summary
The purpose of this study is to develop and test a mobile app for Black/African American breast cancer survivors and their relatives, called Move Together, that promotes sitting less and moving more for better health.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The purpose of this study is to develop and test a mobile app for Black/African American breast cancer survivors and their relatives, called Move Together, that promotes sitting less and moving more for better health.
This is a cross-sectional descriptive study using structured interviews and qualitative data analysis to develop an intervention, followed by a pilot test of the intervention with pre- /post- measures.
-
In study phase 1,involved qualitative interviews with 5 community leader key informants, 9 breast cancer survivors and 6 first degree relatives of a survivor.
-
This part of the research study is a Pilot Study, which means it is the first time that researchers are studying usability and acceptability of the Move Together app.
-
Participants in the pilot study will participate as members of family-based dyads (n=10 dyads). One member of each dyad will be a breast cancer survivor and one will be a blood relative
-
Study involves screening for eligibility, interviews, questionnaires, Use of Move Together app with Garmin activity tracker watch
-
Participation on the trial will be for 5 weeks
-
About 20 people (10 survivors with 10 relatives) will participate in this part of the study, and a total of 58 people in the whole study.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Pilot Study Participants in the pilot study will participate as members of family-based dyads (n=10 dyads). One member of each dyad will be a breast cancer survivor and one will be a blood relative. Study involves interviews, questionnaires, Use of Move Together app with Garmin activity tracker watch |
Other: Move Together app/Garmin Activity Tracker
The Move Together app allows users to set daily goals for increasing physical activity and decreasing sedentary time, track progress on goals, message their buddy, and access external educational infographics and other resource links.
Garmin activity tracker in this study is for participants to track their steps and sedentary time.
|
Outcome Measures
Primary Outcome Measures
- System Usability Scale (SUS) score [Baseline to 4 Weeks]
The acceptability of the Move Together app will also be assessed with The System Usability Scale (SUS) score. The scale has 10 items. Scores range from 0-100; a SUS score above a 68 is considered above average (https://www.usability.gov/how-to-and-tools/methods/system-usability-scale.html.)
Secondary Outcome Measures
- Number of participants screened per month [Baseline to 4 Weeks]
Measurement will be assessed by the completion rates at each time point divided by the number of participants enrolled at each time point
- Number of participants enrolled per month [Baseline to 4 Weeks]
Measurement will be assessed by the completion rates at each time point divided by the number of participants enrolled at each time point
- Completion Rate [Baseline to 4 Weeks]
rate of 70% of all participants completing each of these components per protocol
- Percentage of study days [Baseline to 4 Weeks]
percentage of study days in which the participant uses the Move Together app and will describe engagement with the app. Achieving a minimum of using any app feature 4 out of 7 days will provide an indication of acceptability
- Percentage of participants recruited [Baseline to 4 Weeks]
Percentage of initial respondents who consent and enroll. Achieving a minimum of enrolling 3 dyads per month as an indication of feasibility of recruitment.
- Percentage of participants completed study [Baseline to 4 Weeks]
Achieving a minimum of 70% of those enrolled who complete all study data collection time-points will serve as an indication of the feasibility of the proposed study protocol
- Number of participants retained at the end of 4 weeks [Baseline to 4 Weeks]
Retention will be the number who remain in the study at the end of 4 weeks
Eligibility Criteria
Criteria
Inclusion Criteria:
-
1a) Key informants (for interviews)
-
Members of the community/advisory groups, community health centers, or faith-based network members (e.g., Pink and Black, Faces of Faith).
-
English speaking adults.
-
(1b) Breast cancer survivors and relatives (for interviews)
-
Self-identify as Black or African American
-
Age 18 and over
-
English speaking
-
Female breast cancer survivor status post curative antineoplastic treatment (except ongoing hormonal treatment) with no evidence of disease, OR a first degree blood relative (parent, child, or full sibling), of any gender, of a so defined breast cancer survivor
-
Self-report ever using a smart phone
-
(2) Breast cancer survivors and relatives (for user testing/interviews)
-
Self-identify as Black or African American
-
Age 18 and over
-
English speaking
-
Female breast cancer survivor status post curative antineoplastic treatment (except ongoing hormonal treatment) with no evidence of disease, OR a first degree blood relative (parent, child, or full sibling), of any gender, of a so defined breast cancer survivor
-
Self-report willing/able to download the app for testing on a smart phone
-
Self-report willing/able to meet via Zoom for interview
-
(3) Breast cancer survivors and relatives/"buddies" (for pilot testing)
-
Self-identify as Black or African American
-
Age 18 and over
-
English speaking
-
Breast cancer survivor status post curative antineoplastic treatment (except ongoing hormonal treatment) with no evidence of disease, OR a blood relative, of any gender, of a so defined breast cancer survivor
-
Self-report willing/able to participate with a blood relative in survivor relative dyad
-
Self-report willing/able to download the app for use on a smart phone
-
Self-report willing/able to meet via Zoom for instructions and interview
Exclusion Criteria:
- (1a) Key informants (for interviews)
--None
-
(1b) Breast cancer survivors and relatives (for interviews)
-
Requires medically supervised physical activity (Physical Activity Readiness Question for Everyone, PAR-Q+, Question 7)
-
Pregnant women
-
(2) Breast cancer survivors and relatives (for user testing/interviews)
-
Requires medically supervised physical activity (Physical Activity Readiness Question for Everyone, PAR-Q+, Question 7)
-
Pregnant women
-
(3) Breast cancer survivors and relatives/"buddies" (for pilot testing)
-
Meets exclusion criterion of the Modified Physical Activity Readiness Questionnaire (PAR-Q) (modified)
-
Participated in interviews or user testing in prior phases of the study
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Dana Farber Cancer Institute | Boston | Massachusetts | United States | 02115 |
2 | University of Massachusetts Boston | Boston | Massachusetts | United States | 02125 |
3 | University of Rochester | Rochester | New York | United States | 14627 |
Sponsors and Collaborators
- Dana-Farber Cancer Institute
- University of Massachusetts, Boston
- University of Rochester
- National Cancer Institute (NCI)
Investigators
- Principal Investigator: Catherine Marinac, PhD, Dana-Farber Cancer Institute
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 20-104
- U54CA156732